About: TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 September 2018

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • наукова стаття, опублікована у вересні 2018 (uk)
  • article scientifique publié en 2018 (fr)
  • artículu científicu espublizáu en setiembre de 2018 (ast)
  • scientific article published on 12 September 2018 (en)
  • 2018 թվականի սեպտեմբերի 12-ին հրատարակված գիտական հոդված (hy)
publication date
publication date
author name string
author name string
  • Mattias Rantalainen
  • Luc Y Dirix
  • Steven J Van Laere
  • Dirk Schrijvers
  • Markus Mayrhofer
  • Christophe Ghysel
  • Jeffrey Yachnin
  • Tom Whitington
  • Gert G Van den Eynden
  • Anders Ullén
  • Willem Lybaert
  • Peter Van Oyen
  • Lien Heyrman
  • Wim Demey
  • Alain Bols
  • Michiel Strijbos
  • Lucien Hoekx
  • Annemie Rutten
  • Daan De Maeseneer
  • Barbara Brouwers
  • Anja Brouwer
  • Jozef Ampe
  • Karen Fransis
  • Steffi Oeyen
  • Inge E de Kruijff
  • Pieter-Jan van Dam
rdfs:label
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (en)
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (nl)
skos:prefLabel
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (en)
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (nl)
name
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (en)
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (nl)
author
author
title
title
  • TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (en)
page(s)
page(s)
  • 1766-1773
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 30209161
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software